| SC 13D/A | 2024-03-20 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 6,396,283 | 4.4% | EDGAR |
| SC 13G | 2024-02-14 | ARMISTICE CAPITAL, LLC | Aurinia Pharmaceuticals Inc. | 9,536,000 | 6.6% | EDGAR |
| SC 13G/A | 2024-02-12 | BlackRock Inc. | Aurinia Pharmaceuticals Inc. | 8,921,049 | 6.2% | EDGAR |
| SC 13D/A | 2023-05-10 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 6,060,290 | 4.2% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Aurinia Pharmaceuticals Inc. | 324,238 | 0.2% | EDGAR |
| SC 13G | 2023-02-07 | BlackRock Inc. | Aurinia Pharmaceuticals Inc. | 8,170,518 | 5.7% | EDGAR |
| SC 13D/A | 2023-01-20 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 6,060,290 | 4.3% | EDGAR |
| SC 13D/A | 2023-01-06 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 6,060,290 | 4.3% | EDGAR |
| SC 13G | 2022-10-28 | Deep Track Capital, LP | Aurinia Pharmaceuticals Inc. | 7,841,570 | 5.5% | EDGAR |
| SC 13D/A | 2022-03-03 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 5,708,712 | 4.0% | EDGAR |
| SC 13G/A | 2022-02-14 | HealthCor Management, L.P. | Aurinia Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2021-03-11 | Growth Equity Opportunities Fund III, LLC | Aurinia Pharmaceuticals Inc. | - | - | EDGAR |
| SC 13G/A | 2021-02-17 | Consonance Capital Management LP | Aurinia Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | Consonance Capital Management LP | Aurinia Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | HealthCor Management, L.P. | Aurinia Pharmaceuticals Inc. | 6,937,448 | 5.5% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | Aurinia Pharmaceuticals Inc. | 5,762,773 | 4.6% | EDGAR |
| SC 13D/A | 2021-01-27 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 5,662,468 | 4.5% | EDGAR |
| SC 13D/A | 2021-01-26 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 5,662,468 | 4.5% | EDGAR |
| SC 13D/A | 2020-10-09 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 6,793,847 | 5.4% | EDGAR |
| SC 13D/A | 2020-07-23 | ILJIN SNT Co., Ltd. | Aurinia Pharmaceuticals Inc. | 7,425,338 | 6.5% | EDGAR |